Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Scheltema MJ"" wg kryterium: Wszystkie pola


Tytuł:
Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50
Autorzy:
Gielchinsky I
Scheltema MJ
Cusick T
Chang J
Shnier R
Moses D
Delprado W
Nguyen Q
Yuen C
Haynes A
Stricker PD
Pokaż więcej
Temat:
mpMRI
prostate cancer
young
sensitivity
Diseases of the genitourinary system. Urology
RC870-923
Źródło:
Research and Reports in Urology, Vol Volume 10, Pp 145-150 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/reduced-sensitivity-of-multiparametric-mri-for-clinically-significant--peer-reviewed-article-RRU; https://doaj.org/toc/2253-2447
Dostęp URL:
https://doaj.org/article/b4ec74adc1404b349a97e434a01ce1bf  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
Autorzy:
Ong S; EJ Whitten Foundation Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Vic., Australia.; Department of Surgery, University of Melbourne, Melbourne, Vic., Australia.
Chen K; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Urology, Singapore General Hospital, Singapore City, Singapore.
Grummet J; Department of Surgery, Central Clinical School, Monash University, Melbourne, Vic., Australia.
Yaxley J; The University of Queensland, School of Medicine, Brisbane, QLD, Australia.; Wesley Urology Clinic, Wesley Hospital, Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Scheltema MJ; St. Vincent's Prostate Cancer Research Centre, Darlinghurst, NSW, Australia.; Department of Urology, St Vincents Hospital and Campus, Sydney, NSW, Australia.
Stricker P; St. Vincent's Prostate Cancer Research Centre, Darlinghurst, NSW, Australia.; Department of Urology, St Vincents Hospital and Campus, Sydney, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Tay KJ; Department of Urology, Singapore General Hospital, Singapore City, Singapore.
Lawrentschuk N; EJ Whitten Foundation Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Vic., Australia.; Department of Surgery, University of Melbourne, Melbourne, Vic., Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Urology, Royal Melbourne Hospital, Melbourne, Vic., Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2023 Jan; Vol. 131 (1), pp. 20-31. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/therapy
Urology*
Male ; Humans ; United States ; Aged
Czasopismo naukowe
Tytuł:
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
Autorzy:
van Riel LAMJG; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Geboers B; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Kabaktepe E; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Blazevski A; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Reesink DJ; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Stijns P; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Stricker PD; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Casanova J; Department of Urology, Instituto Valenciano de Oncologia, València, Spain.
Dominguez-Escrig JL; Department of Urology, Instituto Valenciano de Oncologia, València, Spain.
de Reijke TM; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Scheltema MJ; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Nov; Vol. 130 (5), pp. 611-618. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Erectile Dysfunction*/etiology
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Prostate-Specific Antigen ; Retrospective Studies ; Quality of Life ; Neoplasm Recurrence, Local/therapy ; Treatment Outcome ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Salvage Therapy/methods ; Electroporation/methods
Czasopismo naukowe
Tytuł:
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
Autorzy:
Blazevski A; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Scheltema MJ; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; Department of Urology, Amsterdam UMC, Amsterdam, The Netherlands.
Amin A; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.
Thompson JE; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Lawrentschuk N; EJ Whitten Prostate Cancer Research Centre at Epworth Healthcare, Melbourne, Victoria, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Surgery, Olivia Newton-John Cancer Centre, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Stricker PD; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Mar; Vol. 125 (3), pp. 369-378. Date of Electronic Publication: 2019 Dec 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Electroporation*
Ablation Techniques/*methods
Prostatic Neoplasms/*surgery
Biomedical Research ; Forecasting ; Humans ; Male
Czasopismo naukowe
Tytuł:
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Autorzy:
Amin A; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Blazevski A; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Thompson J; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St George Clinical School, University of New South Wales, Sydney, NSW, Australia.
Scheltema MJ; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Department of Urology, UMC, Amsterdam, The Netherlands.
Hofman MS; Centre for Molecular Imaging, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.
Murphy D; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Lawrentschuk N; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Surgery, Austin Health, The University of Melbourne, Parkville, Vic., Australia.; Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic., Australia.
Sathianathen N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Kapoor J; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Woo HH; Sydney Adventist Hospital Clinical School, University of Sydney, Wahroonga, NSW, Australia.; Department of Uro-Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
Chalasani V; University of Sydney, Sydney, NSW, Australia.
Rasiah K; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Department of Urology, Royal North Shore Private Hospital, St Leonards, NSW, Australia.
van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Tang R; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
Cusick T; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Stricker P; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Apr; Vol. 125 (4), pp. 515-524. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Surface*
Gallium Radioisotopes*
Glutamate Carboxypeptidase II*
Multiparametric Magnetic Resonance Imaging*
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms/*diagnostic imaging
Cross-Sectional Studies/methods ; Humans ; Male ; Multicenter Studies as Topic/methods ; Prospective Studies
Czasopismo naukowe
Tytuł:
Diagnostic accuracy of Ga-PSMA PET to mpMRI.
Autorzy:
Scheltema MJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.
Chang JI; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Stricker PD; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
van Leeuwen PJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, The Netherlands.
Nguyen QA; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Ho B; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
Delprado W; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.
Lee J; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
Thompson JE; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Cusick T; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Spriensma AS; Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.
Siriwardana AR; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Yuen C; St Vincent's Clinic, Darlinghurst, NSW, Australia.
Kooner R; St Vincent's Clinic, Darlinghurst, NSW, Australia.
Hruby G; Genesis Cancer Care, St Vincent's Hospital, Darlinghurst, NSW, Australia.
O'Neill G; St Vincent's Clinic, Darlinghurst, NSW, Australia.
Emmett L; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2019 Nov; Vol. 124 Suppl 1, pp. 42-49. Date of Electronic Publication: 2019 Jul 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiparametric Magnetic Resonance Imaging*
Positron Emission Tomography Computed Tomography*
Prostatectomy*
Gallium Radioisotopes/*pharmacology
Prostate/*pathology
Prostatic Neoplasms/*pathology
Radiopharmaceuticals/*pharmacology
Aged ; Dimensional Measurement Accuracy ; Health Care Surveys ; Humans ; Male ; Middle Aged ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/analysis ; Prostatic Neoplasms/diagnostic imaging ; ROC Curve ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies